| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |